Literature DB >> 14669820

Presence of cortistatin in the human pancreas.

M Papotti1, E Tarabra, E Allia, F Bozzalla-Cassione, F Broglio, R Deghenghi, E Ghigo, G Muccioli.   

Abstract

Cortistatin (CST), a 17-amino acid peptide partially homologous to somatostatin (SRIF), has been originally isolated from the cerebral cortex and recently found in monocytes and macrophages of the immune system. CST binds all 5 SRIF receptors, as well the GH secretagogue (GHS)/ghrelin receptors. CST exerts sleep promoting activities, acts on animal motility and behavior and inhibits GH and insulin secretion. To investigate the possible occurrence and activities in peripheral tissues, expression of CST at the mRNA and peptide level was analyzed in the human pancreas by means of RT-PCR, in situ hybridization and immunohistochemistry. The specific CST mRNA was found in 3 of 4 pancreatic RNA extracts and in the control cerebral cortex. By in situ hybridization, CST mRNA was localized in the pancreatic islets, but not in the exocrine pancreas. This finding was confirmed by immunostaining with a specific antibody to CST-17 which detected CST in single islet cells. These cells also expressed SRIF receptors types 2, 3 and 5, ghrelin and GHS receptors. Thus, our findings show the presence of CST in the human endocrine pancreas. Local autocrine or paracrine circuits, only in part overlapped with those of SRIF, may be active to modulate insulin and/or glucagon levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669820     DOI: 10.1007/BF03347348

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.

Authors:  M Papotti; M Bongiovanni; M Volante; E Allìa; S Landolfi; L Helboe; M Schindler; S L Cole; G Bussolati
Journal:  Virchows Arch       Date:  2002-03-23       Impact factor: 4.064

2.  Cortistatin is expressed in a distinct subset of cortical interneurons.

Authors:  L de Lecea; J A del Rio; J R Criado; S Alcántara; M Morales; P E Danielson; S J Henriksen; E Soriano; J G Sutcliffe
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Ghrelin and insulin metabolism.

Authors:  O Ukkola
Journal:  Eur J Clin Invest       Date:  2003-03       Impact factor: 4.686

4.  Cortistatin modulates memory processes in rats.

Authors:  M Sánchez-Alavez; M Gómez-Chavarín; L Navarro; A Jiménez-Anguiano; E Murillo-Rodríguez; R A Prado-Alcalá; R Drucker-Colin; O Prospéro-García
Journal:  Brain Res       Date:  2000-03-06       Impact factor: 3.252

5.  Peptides, sleep and cortistatin.

Authors:  L de Lecea; J G Sutcliffe
Journal:  Mol Psychiatry       Date:  1996-11       Impact factor: 15.992

Review 6.  Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor.

Authors:  M Kojima; H Hosoda; K Kangawa
Journal:  Horm Res       Date:  2001

7.  Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.

Authors:  F Broglio; E Arvat; A Benso; C Gottero; G Muccioli; M Papotti; A J van der Lely; R Deghenghi; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

8.  Ghrelin-producing endocrine tumors of the stomach and intestine.

Authors:  M Papotti; P Cassoni; M Volante; R Deghenghi; G Muccioli; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

9.  Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels.

Authors:  Maura Arosio; Cristina L Ronchi; Carlotta Gebbia; Vincenzo Cappiello; Paolo Beck-Peccoz; Maddalena Peracchi
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

10.  Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.

Authors:  Fabio Broglio; Peter van Koetsveld Pv; Andrea Benso; Cristina Gottero; Flavia Prodam; Mauro Papotti; Giampiero Muccioli; Carlotta Gauna; Leo Hofland; Romano Deghenghi; Emanuela Arvat; Aart Jan Van Der Lely; Ezio Ghigo
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

View more
  3 in total

1.  Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas.

Authors:  Beléen Chanclón; Antonio J Martínez-Fuentes; Francisco Gracia-Navarro
Journal:  Front Endocrinol (Lausanne)       Date:  2012-09-18       Impact factor: 5.555

Review 2.  Biological redundancy of endogenous GPCR ligands in the gut and the potential for endogenous functional selectivity.

Authors:  Georgina L Thompson; Meritxell Canals; Daniel P Poole
Journal:  Front Pharmacol       Date:  2014-11-28       Impact factor: 5.810

3.  Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-11       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.